Skip to content

HQL

abrdn Life Sciences Investors

NYSE · Financial Services · Asset Management · US

$19.41
−0.82%
Ask drillr
Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open
$19.57
From 52W high
−14.38%
Volume
87448.00
Market cap
$560.41M
P/E (Fwd)
EV/EBITDA
6.5x
P/E (TTM)
6.6x
RSI (14)
34.0
1D Return
−0.82%
YTD Return
+14.84%
SummaryUpdated Mar 1, 2026

Tekla Life Sciences Investors (NYSE:HQL) is a closed-end investment fund that has been operating since 1992, making it one of the longest-running specialized life sciences investment vehicles in the public markets. Originally known as H&Q Life Sciences Investors, the fund was launched during the early boom years of biotechnology investing and has since evolved to become a focused player in the life sciences investment space. The fund is managed by Tekla Capital Management LLC and trades as a publicly listed closed-end fund, allowing individual and institutional investors to gain exposure to a diversified portfolio of life sciences companies through a single investment vehicle.

Similar companies

Latest newsMore news →

No recent news for HQL.